EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink tough lung cancers
Disease control Not yet recruitingThis study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose cancer has come back after prior treatment. The goal is to see if the combo can shrink tumors and delay cancer growth. About 33 adults a…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for tough lung cancer: chemo-radiation combo enters trial
Disease control Not yet recruitingThis study tests a new treatment for people with advanced small-cell lung cancer whose cancer got worse after initial therapy. The treatment combines a chemotherapy drug called nab-paclitaxel with targeted radiation. The goal is to see if this combination can slow cancer growth a…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 13, 2026 15:58 UTC